| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373312A1 Shellfish protein |
| 01/02/2004 | EP1373311A2 Method for improving plant tolerance to environmental stress |
| 01/02/2004 | EP1373310A2 Staphylococcus aureus proteins and nucleic acids |
| 01/02/2004 | EP1373308A2 Multimerization of hiv-1 vif protein as a therapeutic target |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373302A1 Method for purification of molecules using unbranched terminal alkyldiols |
| 01/02/2004 | EP1373301A2 Reducing the immunogenicity of fusion proteins |
| 01/02/2004 | EP1373299A2 Connective tissue growth factor-2 |
| 01/02/2004 | EP1373295A2 Regulatable growth of filamentous fungi |
| 01/02/2004 | EP1373294A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1373292A2 Cell cycle nucleic acids, polypeptides and uses thereof |
| 01/02/2004 | EP1373285A2 Synthesis and use of glycodendrimer reagents |
| 01/02/2004 | EP1372828A2 Biochips including ion transport detecting structures and methods of use |
| 01/02/2004 | EP1372736A2 Anti-neovasculature preparations for cancer |
| 01/02/2004 | EP1372719A2 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 01/02/2004 | EP1372711A2 Compositions and methods comprising west nile virus polypeptides |
| 01/02/2004 | EP1372710A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/02/2004 | EP1372709A2 Intimins for the prevention or treatment of infections: i |
| 01/02/2004 | EP1372705A2 Leishmania vaccines |
| 01/02/2004 | EP1372700A1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 01/02/2004 | EP1372696A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/02/2004 | EP1372691A2 Mucin peptide with immunoenhancing properties |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1372689A2 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 01/02/2004 | EP1372688A2 Somatostatin antagonists |
| 01/02/2004 | EP1372686A4 Methods and compositions for peptide synthesis |
| 01/02/2004 | EP1372686A2 Methods and compositions for peptide synthesis |
| 01/02/2004 | EP1372634A2 Fumaric acid amides |
| 01/02/2004 | EP1372418A2 Non-oligomerizing tandem fluorescent proteins |
| 01/02/2004 | EP0910623B1 Thrombin receptor modified transgenic animals |
| 01/02/2004 | EP0871664B1 Mobilization of hematopoietic stem cells using a chemokine |
| 01/02/2004 | EP0831921B1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/02/2004 | EP0719343B1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 01/01/2004 | US20040003433 Cell cycle nucleic acids, polypeptides and uses thereof |
| 01/01/2004 | US20040003428 A polynucleotide having a nucleotide sequence encoding amino acid sequence from methionine at position 1 to serine at position 361 of preferred amino acid or sequence having one or more amino acid deletion, insertion or substitution |
| 01/01/2004 | US20040003427 Novel basal endosperm transfer cell layer (BELT) specific genes |
| 01/01/2004 | US20040003425 Nav2 channel gene-deficient non-human animals |
| 01/01/2004 | US20040003422 An expression cassette containing the proopiomelanocortin (POMC) enhancer, and a nucleic acid sequence encoding POMC contains at least one exon, wherein a polylinker having an unique site for restriction enzyme is inserted into the exon; gene regulates weight and fat mass |
| 01/01/2004 | US20040003420 A fusion protein containing a recombinase domain consists of a recombinase protein or a mutant having a recombinase activity similar to wild type recombinase, and a signal peptide domain linked to such recombinase domain |
| 01/01/2004 | US20040003419 Novel taste receptors in Drosophila |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040003417 Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
| 01/01/2004 | US20040003079 Systems and methods to regulate use of consumer devices and services |
| 01/01/2004 | US20040002593 PAAD - (pyrin, AIM (absent in melanoma), ASC ( apoptosis -associated speck-like protein containing a capsase-recruitment domain -CARD)); identifying agents that modulate PAAD domain-mediated inhibition of NF kappa B activity |
| 01/01/2004 | US20040002591 50 human secreted proteins |
| 01/01/2004 | US20040002586 Crystal structure of interleukin-22 and uses thereof |
| 01/01/2004 | US20040002585 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040002584 Proteins, polynucleotides encoding them and methods of using the same |
| 01/01/2004 | US20040002582 Miniprotein ligands and other polypeptides and methods for making and using same |
| 01/01/2004 | US20040002581 Peptides and use thereof in therapeutic agents against HIV infection |
| 01/01/2004 | US20040002474 IFN-alpha homologues |
| 01/01/2004 | US20040002471 Human nucleic acid sequences which are overexpressed in normal pancreas tissue |
| 01/01/2004 | US20040002470 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 01/01/2004 | US20040002469 Administering genetic engineered polynucleotide which codes heat shock protein; induce immunology response |
| 01/01/2004 | US20040002468 Methods of treating diabetes and other blood sugar disorders |
| 01/01/2004 | US20040002460 Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom |
| 01/01/2004 | US20040002458 Pharmaceutical compositions and methods using natriuretic peptides |
| 01/01/2004 | US20040002457 Prevention binding of cells to protein; therapy for Aids; viricides |
| 01/01/2004 | US20040002456 Methods and devices for preparing protein concentrates |
| 01/01/2004 | US20040002453 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/01/2004 | US20040002450 Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002443 Immobilization hemoglobin protein with polyoxyethylene glycol |
| 01/01/2004 | US20040002442 Antidiabetic agents; obesity therapy; autoimmune disease |
| 01/01/2004 | US20040002440 Modulation gene expression; binding antigen to polypeptide; therapy for infection |
| 01/01/2004 | US20040002439 Human voltage gated sodium channel beta1A subunit and methods of use |
| 01/01/2004 | US20040002149 Control of the ratio of LAP to LIP |
| 01/01/2004 | US20040002145 Colony stimulating factors (cFMS); crystal proteins; drug screening |
| 01/01/2004 | US20040002144 Extrapolating the structure-binding site by replacing, inserting or deleting amino acids; x-ray crystal structure analysis; streptoverticillium mobaraense |
| 01/01/2004 | US20040002141 Methods and compositions for propagating vectors containing toxic cDNAs and ion channel assay systems |
| 01/01/2004 | US20040002140 Growth factor homolog ZVEGF4 |
| 01/01/2004 | US20040002139 Methods for making recombinant proteins using apoptosis inhibitors |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002124 Cyr61 compositions and methods |
| 01/01/2004 | US20040002122 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/01/2004 | US20040002120 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/01/2004 | US20040002116 Simple method of cloning, overexpressing and purifying lens protein tau-crystallin |
| 01/01/2004 | US20040002114 Nucleic acids encoding a G-protein coupled receptor involved in islet cell signaling |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |
| 01/01/2004 | US20040002112 Identifying and/or quantitating proteins differentially expressed in one or more specific stage(s) of adipocyte differentiation, using mass spectrometry |
| 01/01/2004 | US20040002109 Process for identifying modulators of G-protein-coupled receptors |
| 01/01/2004 | US20040002107 Promoter sequences for urocortin II and the use thereof |
| 01/01/2004 | US20040002103 Synthetic ligation reassembly in directed evolution |
| 01/01/2004 | US20040002102 Methods of detecting the presence of BIVM nucleic acids or polypeptides in samples suspected of containing BIVM genes, BIVM transcriptional products, or BIVM translational products |
| 01/01/2004 | US20040002100 Comprises assaying a suppressing effect of a test substance on an expression of a splicing variant transcribed from presenilin-2 gene |
| 01/01/2004 | US20040002099 Genes and genetic elements associated with sensitivity to platinum-based drugs |
| 01/01/2004 | US20040002096 Wild-type isoforms and mutations of Ikaros, and nucleic acid sequences encoding Ikaros, useful in the diagnosis and treatment of hematologic malignancy, particularly lymphoid malignancy, including leukemia, |
| 01/01/2004 | US20040002088 Identification and isolation of novel DNA and to the recombinant production of polypeptides having sequence similarity to Glial Cell line-derived Neurotrophic Factor Receptor (GDNFR) |
| 01/01/2004 | US20040002087 Nucleic acid for detecting endocrine disrupting property of chemical substance, nucleic acid detecting probe and nucleic acid detecting primer containing the nucleic acid, probe-immobilized chip comprising the nucleic acid detecting probe, peptide derived from the nucleic acid and antibody recognizing the peptide, probe-immobilized chip comprising the antibody, and method of detecting endocrine disrupting property of chemical substance using them |
| 01/01/2004 | US20040002084 Identifying agents or compositions useful in the treatment of asthma or in methods for diagnosing or identifying eosinophil-related disorders in humans and mammals |
| 01/01/2004 | US20040002076 Sequencing and performing polymerase reactions using an improved generation of nucleic acid polymerases; comprises fusion of a sequence-non-specific nucleic-acid-binding domain to the enzyme to enhances the processivity of the polymerase |
| 01/01/2004 | US20040002068 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040002060 For efficient targeting of adenoviral vectors; can be combined with other modifications, such as fiber knob and/or penton modifications, to produce fully ablated (detargeted) adenoviral vectors |
| 01/01/2004 | US20040002059 Screening method and a screening system capable of selecting agents capable of interfering with this protein-protein interaction; selection of agents capable of modulating this protein-protein interaction for treatment and control of PV |
| 01/01/2004 | US20040002058 Chimeric capsid proteins and uses thereof |
| 01/01/2004 | US20040002057 Cloning vectors and methods for producing a library of DNA molecules capable of expressing a fusion polypeptide on the surface of a filamentous phage particle |
| 01/01/2004 | US20040002056 Used in methods of screening for candidate bioactive agents that produce an altered phenotype in the cells |